======= HOGA1 ======= == Gene Information == * **Official Symbol**: HOGA1 * **Official Name**: 4-hydroxy-2-oxoglutarate aldolase 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=112817|112817]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q86XE5|Q86XE5]] * **Interactions**: [[https://thebiogrid.org/search.php?search=HOGA1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20HOGA1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/613597|Open OMIM]] == Function Summary == * **Entrez Summary**: The authors of PMID:20797690 cloned this gene while searching for genes in a region of chromosome 10 linked to primary hyperoxalurea type III. They noted that even though the encoded protein has been described as a mitochondrial dihydrodipicolinate synthase-like enzyme, it shares little homology with E. coli dihydrodipicolinate synthase (Dhdps), particularly in the putative substrate-binding region. Moreover, neither lysine biosynthesis nor sialic acid metabolism, for which Dhdps is responsible, occurs in vertebrate mitochondria. They propose that this gene encodes mitochondrial 4-hydroxyl-2-oxoglutarate aldolase (EC 4.1.3.16), which catalyzes the final step in the metabolic pathway of hydroxyproline, releasing glyoxylate and pyruvate. This gene is predominantly expressed in the liver and kidney, and mutations in this gene are found in patients with primary hyperoxalurea type III. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Nov 2010]. * **UniProt Summary**: Catalyzes the final step in the metabolic pathway of hydroxyproline. {ECO:0000269|PubMed:20797690, ECO:0000269|PubMed:21998747}. |DHDPS| |oxalate metabolic process| |4-hydroxy-2-oxoglutarate aldolase activity| |glyoxylate catabolic process| |4-hydroxyproline catabolic process| |pyruvate biosynthetic process| |glyoxylate metabolic process| |aldehyde catabolic process| |4-hydroxyproline metabolic process| |cellular modified amino acid catabolic process| |cellular aldehyde metabolic process| |pyruvate metabolic process| |dicarboxylic acid metabolic process| |alpha-amino acid catabolic process| |monocarboxylic acid catabolic process| |cellular amino acid catabolic process| |monocarboxylic acid biosynthetic process| |cellular modified amino acid metabolic process| |alpha-amino acid metabolic process| |organic acid catabolic process| |carboxylic acid catabolic process| |carboxylic acid biosynthetic process| |organic acid biosynthetic process| |cellular amino acid metabolic process| |mitochondrial matrix| |small molecule catabolic process| |monocarboxylic acid metabolic process| |small molecule biosynthetic process| |protein homodimerization activity| |carboxylic acid metabolic process| |oxoacid metabolic process| |organic acid metabolic process| |organonitrogen compound catabolic process| |mitochondrion| |small molecule metabolic process| |organic substance catabolic process| |cellular catabolic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp198|Etoposide 0.1μM R05 exp198]]|1.7| |[[:results:exp49|NFN1 0.1μM R01 exp49]]|1.75| |[[:results:exp500|LY2090314 0.003μM R08 exp500 no dilution day6]]|1.91| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 10989 * **Expression level (log2 read counts)**: 2.36 {{:chemogenomics:nalm6 dist.png?nolink |}}